林宜玲博士
特聘研究員
Division Chief
- 02-2789-9013 (Lab) (Room No: 443)
- 02-2652-3902
- 02-2785-8847 (Fax)
-
Specialty:
- Molecular Virology
- Viral Pathogenesis
- Viral Immunology
Education and Positions:
1992, PhD, University of California, Los Angeles (UCLA), USA
2020 ~ date, CEO, Emerging Infectious Disease Division (EIDD), Biomedical Translation Research Center (BioTReC), Academia Sinica
Contact Information:
Dr. Lin, Yi-Ling 's
Research Highlights
Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission
Journal of Biomedical Science, Oct 12, 2023
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan
Journal of Microbiology, Immunology and Infection, Jun 07, 2023
Optimization and Improvement of qPCR Detection Sensitivity of SARS-CoV-2 in Saliva
Microbiology Spectrum, Apr 25, 2023
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
Scientific Report , Apr 22, 2021